241 related articles for article (PubMed ID: 19672595)
1. Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
Bouwhuis MG; Gast A; Figl A; Eggermont AM; Hemminki K; Schadendorf D; Kumar R
Cancer Immunol Immunother; 2010 Feb; 59(2):303-12. PubMed ID: 19672595
[TBL] [Abstract][Full Text] [Related]
2. Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis.
Kim YO; Kim HJ; Kim SK; Chung JH; Hong SJ
Clin Chem Lab Med; 2010 Mar; 48(3):345-53. PubMed ID: 20113255
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CD28, CTLA4, and ICOS polymorphisms in three Brazilian ethnic groups.
Guzman VB; Morgun A; Shulzhenko N; Mine KL; Gonçalves-Primo A; Musatti CC; Gerbase-Delima M
Hum Immunol; 2005 Jul; 66(7):773-6. PubMed ID: 16112024
[TBL] [Abstract][Full Text] [Related]
4. CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population.
Walker EJ; Hirschfield GM; Xu C; Lu Y; Liu X; Lu Y; Coltescu C; Wang K; Newman WG; Bykerk V; Keystone EC; Mosher D; Amos CI; Heathcote EJ; Siminovitch KA
Arthritis Rheum; 2009 Apr; 60(4):931-7. PubMed ID: 19333938
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease.
Ban Y; Davies TF; Greenberg DA; Kissin A; Marder B; Murphy B; Concepcion ES; Villanueva RB; Barbesino G; Ling V; Tomer Y
Genes Immun; 2003 Dec; 4(8):586-93. PubMed ID: 14647199
[TBL] [Abstract][Full Text] [Related]
6. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study.
Cunninghame Graham DS; Wong AK; McHugh NJ; Whittaker JC; Vyse TJ
Hum Mol Genet; 2006 Nov; 15(21):3195-205. PubMed ID: 17000707
[TBL] [Abstract][Full Text] [Related]
7. Association of CTLA4, CD28 and ICOS gene polymorphisms with clinicopathologic characteristics of childhood IgA nephropathy in Korean population.
Kim HJ; Chung JH; Kang S; Kim SK; Cho BS; Kim SD; Hahn WH
J Genet; 2011 Apr; 90(1):151-5. PubMed ID: 21677403
[No Abstract] [Full Text] [Related]
8. Genetic polymorphism of the human ICOS gene.
Haimila KE; Partanen JA; Holopainen PM
Immunogenetics; 2002 Mar; 53(12):1028-32. PubMed ID: 11904679
[TBL] [Abstract][Full Text] [Related]
9. Investigation of
Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485
[TBL] [Abstract][Full Text] [Related]
10. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
[TBL] [Abstract][Full Text] [Related]
11. Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients.
Saadi MI; Yaghobi R; Karimi MH; Geramizadeh B; Ramzi M; Zakerinia M
Mol Biol Rep; 2013 Oct; 40(10):5833-42. PubMed ID: 24057239
[TBL] [Abstract][Full Text] [Related]
12. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Ihara K; Ahmed S; Nakao F; Kinukawa N; Kuromaru R; Matsuura N; Iwata I; Nagafuchi S; Kohno H; Miyako K; Hara T
Immunogenetics; 2001 Aug; 53(6):447-54. PubMed ID: 11685455
[TBL] [Abstract][Full Text] [Related]
13. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
14. No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.
Wiencke K; Boberg KM; Donaldson P; Harbo H; Ling V; Schrumpf E; Spurkland A
Scand J Gastroenterol; 2006 May; 41(5):586-91. PubMed ID: 16638702
[TBL] [Abstract][Full Text] [Related]
15. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of the T-cell coreceptors CD28 and CTLA-4 in Afro- and Euro-Brazilians.
Pincerati MR; Dalla-Costa R; Pavoni DP; Petzl-Erler ML
Int J Immunogenet; 2010 Aug; 37(4):253-61. PubMed ID: 20477885
[TBL] [Abstract][Full Text] [Related]
17. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
[TBL] [Abstract][Full Text] [Related]
18. Association study between polymorphisms of CD28, CTLA4 and ICOS and non-segmental vitiligo in a Korean population.
Shin MK; Im SH; Park HJ; Kim SK; Yim SV; Chung JH; Lee MH
Exp Ther Med; 2011 Nov; 2(6):1145-1149. PubMed ID: 22977635
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients.
Karimi MH; Motazedian M; Abedi F; Yaghobi R; Geramizadeh B; Nikeghbalian S
Gene; 2012 Aug; 504(1):127-32. PubMed ID: 22579879
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory gene polymorphisms in women with preeclampsia.
Pendeloski KP; Sass N; Torloni MR; Mattar R; Moron AF; Franchim CS; Daher S
Hypertens Res; 2011 Mar; 34(3):384-8. PubMed ID: 21160481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
